Glycaemic control in individuals with type 1 diabetes using an open source artificial pancreas system (OpenAPS).

Melmer, Andreas; Züger, Thomas; Lewis, Dana M; Leibrand, Scott; Stettler, Christoph; Laimer, Markus (2019). Glycaemic control in individuals with type 1 diabetes using an open source artificial pancreas system (OpenAPS). Diabetes, obesity & metabolism, 21(10), pp. 2333-2337. Wiley 10.1111/dom.13810

[img] Text
Melmer_et_al-2019-Diabetes,_Obesity_and_Metabolism.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (375kB) | Request a copy

Open source artificial pancreas systems (OpenAPS) have gained considerable interest in the diabetes community. We analyzed continuous glucose monitoring (CGM) records of 80 OpenAPS users with type 1 diabetes (T1D). A total of 19 495 days (53.4 years) of CGM records were available. Mean glucose was 7.6 ± 1.1 mmol/L, time in range 3.9-10 mmol/L was 77.5 ± 10.5%, <3.9 mmol/L was 4.3 ± 3.6%, <3.0 mmol/L was 1.3 ± 1.9%, >10 mmol/L was 18.2 ± 11.0% and > 13.9 mmol/L was 4.1 ± 4.0%, respectively. In 34 OpenAPS users, additional CGM records were obtained while using sensor-augmented pump therapy (SAP). After changing from SAP to OpenAPS, lower mean glucose (-0.6 ± 0.7; P < 0.0001), lower estimated HbA1c (-0.4 ± 0.5%; P < 0.0001), higher time in range 3.9-10 mmol/L (+9.3 ± 9.5%; P < 0.0001), less time < 3.0 mmol/L (-0.7 ± 2.2%; P = 0.0171), lower coefficient of variation (-2.4 ± 5.8; P = 0.0198) and lower mean of daily differences (-0.6 ± 0.9 mmol/L; P = 0.0005) was observed. Glycaemic control using OpenAPS was comparable with results of more rigorously developed and tested AP systems. However, OpenAPS was used by a highly selective, motivated and technology-adept cohort, despite not being approved for the treatment of individuals with T1D.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Endocrinology, Diabetology and Clinical Nutrition

UniBE Contributor:

Melmer, Andreas, Züger, Thomas Johannes, Stettler, Christoph, Laimer, Markus

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1463-1326

Publisher:

Wiley

Language:

English

Submitter:

Markus Laimer

Date Deposited:

18 Sep 2019 16:47

Last Modified:

05 Dec 2022 15:30

Publisher DOI:

10.1111/dom.13810

PubMed ID:

31183929

Uncontrolled Keywords:

artificial pancreas glycaemic control glycaemic variability open source type 1 diabetes

BORIS DOI:

10.7892/boris.133295

URI:

https://boris.unibe.ch/id/eprint/133295

Actions (login required)

Edit item Edit item
Provide Feedback